Olga Kočková

Dr. Olga Kočková


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 January 2024 in ACS Sustainable Chemistry & Engineering
Verified
Journal Article
Open access
OGOlga Gotkiewicz
Olga Gotkiewicz
MKMikelis Kirpluks
Mikelis Kirpluks
ZWZuzana Walterová
Zuzana Walterová
OKOlga Kočková
Olga Kočková
SASabina Abbrent
Sabina Abbrent
HBHynek Beneš
Hynek Beneš

29 June 2024 in Biomacromolecules
Verified
Journal Article
Open access
NMNikola Matějková
Nikola Matějková
LKLucie Korecka
Lucie Korecka
Petr ŠálekPetr Šálek
Petr Šálek
OKOlga Kočková
Olga Kočková
EPEwa Pavlova
Ewa Pavlova
ZBZuzana Bílková
Zuzana Bílková
Hyaluronic acid is an excellent biocompatible material for in vivo applications. Its ability to bind CD44, a cell receptor involved in numerous biological processes, predetermines HA-based nanomaterials as unique carrier for therapeutic and theranostic applications. Although numerous methods for the synthesis of hyaluronic acid nanoparticles (HANPs) are available today, their low reproducibility and wide size distribution hinder the precise assessment of the effect on the organism. A robust and reproducible approach for producing HANPs that meet strict criteria for in vivo applications (e.g., to lung parenchyma) remains challenging. We designed and evaluated four protocols for the preparation of HANPs with those required parameters. The HA molecule was cross-linked by novel combinations of carbodiimide, and four different amine-containing compounds resulted in monodisperse HANPs with a low polydispersity index. By a complex postsynthetic characterization, we confirmed that the prepared HANPs meet the criteria for inhaled therapeutic delivery and other in vivo applications.


16 January 2021 in Nanomaterials
Verified
Journal Article
Open access
PDF file
OSOleksandr Shapoval
Oleksandr Shapoval
VOViktoriia Oleksa
Viktoriia Oleksa
Miroslav SloufMiroslav Slouf
Miroslav Slouf
VLVolodymyr Lobaz
Volodymyr Lobaz
OKOlga Kočková
Olga Kočková
DHDaniel Horak
Daniel Horak
Multimodal imaging, integrating several modalities including down- and up-conversion luminescence, T1- and T2(T2*)-weighted MRI, and CT contrasting in one system, is very promising for improved diagnosis of severe medical disorders. To reach the goal, it is necessary to develop suitable nanoparticles that are highly colloidally stable in biologically relevant media. Here, hydrophilic poly(N,N-dimethylacrylamide-N-acryloylglycine methyl ester)-alendronate-[P(DMA-AGME)-Ale]-coated Gd(Tb)F3:Tb3+(Gd3+),Yb3+,Nd3+ nanoparticles were synthesized by a coprecipitation method in ethylene glycol (EG) followed by coating with the polymer. The particles were tho-roughly characterized by a dynamic light scattering (DLS), transmission electron microscopy (TEM), Fourier-transform infrared spectroscopy (FTIR), thermogravimetric analysis (TGA), X-ray energy dispersive spectroscopy (EDAX), selected area electron diffraction (SAED), elemental ana-lysis and fluorescence spectroscopy. Aqueous particle dispersions exhibited excellent colloidal stability in water and physiological buffers. In vitro toxicity assessments suggested no or only mild toxicity of the surface-engineered Gd(Tb)F3:Tb3+(Gd3+),Yb3+,Nd3+ particles in a wide range of concentrations. Internalization of the particles by several types of cells, including HeLa, HF, HepG2, and INS, was confirmed by a down- and up-conversion confocal microscopy. Newly developed particles thus proved to be an efficient contrast agent for fluorescence imaging, T1- and T2(T2*)-weighted magnetic resonance imaging (MRI), and computed tomography (CT).

21 April 2024 in Chemical Engineering Journal
Verified
Journal Article
Open access
MKMaria Kurańska
Maria Kurańska
HBHynek Benes
Hynek Benes
OKOlga Kočková
Olga Kočková
MKMichał Kucała
Michał Kucała
EMElżbieta Malewska
Elżbieta Malewska
APAleksander Prociak
Aleksander Prociak

28 November 2023 in Pharmaceutics
Verified
Journal Article
Open access
PDF file
OSOleksandr Shapoval
Oleksandr Shapoval
David VetvickaDavid Vetvicka
David Vetvicka
VPVitalii Patsula
Vitalii Patsula
HEHana Engstová
Hana Engstová
OKOlga Kočková
Olga Kočková
DHDaniel Horak
Daniel Horak
Upconverting nanoparticles are interesting materials that have the potential for use in many applications ranging from solar energy harvesting to biosensing, light-triggered drug delivery, and photodynamic therapy (PDT). One of the main requirements for the particles is their surface modification, in our case using poly(methyl vinyl ether-alt-maleic acid) (PMVEMA) and temoporfin (THPC) photosensitizer to ensure the colloidal and chemical stability of the particles in aqueous media and the formation of singlet oxygen after NIR irradiation, respectively. Codoping of Fe2+, Yb3+, and Er3+ ions in the NaYF4 host induced upconversion emission of particles in the red region, which is dominant for achieving direct excitation of THPC. Novel monodisperse PMVEMA-coated upconversion NaYF4:Yb3+,Er3+,Fe2+ nanoparticles (UCNPs) with chemically bonded THPC were found to efficiently transfer energy and generate singlet oxygen. The cytotoxicity of the UCNPs was determined in the human pancreatic adenocarcinoma cell lines Capan-2, PANC-01, and PA-TU-8902. In vitro data demonstrated enhanced uptake of UCNP@PMVEMA-THPC particles by rat INS-1E insulinoma cells, followed by significant cell destruction after excitation with a 980 nm laser. Intratumoral administration of these nanoconjugates into a mouse model of human pancreatic adenocarcinoma caused extensive necrosis at the tumor site, followed by tumor suppression after NIR-induced PDT. In vitro and in vivo results thus suggest that this nanoconjugate is a promising candidate for NIR-induced PDT of cancer.